The Last Of Us In Therapy
UKnowledge (University of Kentucky) · 25.07.2023
DOI: 10.13023/jpns1223 ↗Kurz gefasst
Fachartikel in der Zeitschrift UKnowledge (University of Kentucky), erschienen am 25.07.2023. Verfasst von Anastasia Lyon.
Abstract (Originalsprache)
The "psilocybiome" represents the mutually beneficial relationship between ourselves, our bacteria, and psychedelic drugs. This short review briefly discusses the benefits and limitations surrounding the potential for psychedelic therapy to synergize with gut bacteria to help regulate and maintain proper balance in the immune system, diet, and stress levels. Psychedelic therapy is a novel treatment strategy that has the potential to improve patient mental health, and, by identifying the types of gut bacteria present in patients, it can aid in personalizing medicine by determining how well their "psilocybiome" may respond.
Schlagwörter
Zitieren
APA
Lyon, A. (2023). The Last Of Us In Therapy. UKnowledge (University of Kentucky). https://doi.org/10.13023/jpns1223
Vancouver
Lyon A. The Last Of Us In Therapy. UKnowledge (University of Kentucky). 2023. doi:10.13023/jpns1223
BibTeX
@article{Lyon2023,
author = {Lyon, Anastasia},
title = {The Last Of Us In Therapy},
journal = {UKnowledge (University of Kentucky)},
year = {2023},
doi = {10.13023/jpns1223}
}
EUVIMED